ARQT
Arcutis Biotherapeutics Inc
27.80$
+7.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 20.5% | 8.4% | 9.7% | 9.8% | |
| – | – | – | – | – | 79.5% | 91.6% | 90.3% | 90.2% | |
| – | – | – | – | – | 4,949.4% | 185.5% | 38.9% | 20.5% | |
| – | – | – | – | – | 3,313.2% | 291.1% | 113.2% | 73.0% | |
| – | – | – | – | – | 8,262.6% | 496.1% | 155.6% | 93.5% | |
| – | – | – | – | – | -8,183.0% | -404.5% | -65.3% | -3.3% | |
| – | – | – | – | – | 424.6% | 49.8% | 13.8% | 3.2% | |
| – | – | – | – | – | -8,449.8% | -434.6% | -70.9% | -4.0% | |
| – | – | – | – | – | 266.7% | 5.2% | 0.3% | 0.3% | |
| – | – | – | – | – | -8,449.8% | -439.8% | -71.3% | -4.3% | |
| – | – | – | – | – | -7,991.1% | -381.6% | -55.8% | 0.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.